本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ventyx Biosciences, Inc.

1.59
+0.14009.66%
盘后1.590.00000.00%19:52 EDT
成交量:169.10万
成交额:262.46万
市值:1.13亿
市盈率:-0.91
高:1.62
开:1.44
低:1.38
收:1.45
数据加载中...
2024/06/05

重要事件披露

Form 8-K - Current report
2024/05/16

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/26

SEC问询函

Form CORRESP - Correspondence
2024/04/05

重要事件披露

Form 8-K - Current report
2024/04/04

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]